137 related articles for article (PubMed ID: 6299362)
1. Properties of the cyclic GMP phosphodiesterase from rat lung. Inhibition by unsaturated fatty acids.
Coquil JF
Biochim Biophys Acta; 1983 Mar; 743(3):359-69. PubMed ID: 6299362
[TBL] [Abstract][Full Text] [Related]
2. Effects of fatty acids on activity of cGMP-stimulated cyclic nucleotide phosphodiesterase from calf liver.
Yamamoto T; Yamamoto S; Manganiello VC; Vaughan M
Arch Biochem Biophys; 1984 Feb; 229(1):81-9. PubMed ID: 6322693
[TBL] [Abstract][Full Text] [Related]
3. Resolution of soluble cyclic nucleotide phosphodiesterase isoenzymes, from liver and hepatocytes, identifies a novel IBMX-insensitive form.
Lavan BE; Lakey T; Houslay MD
Biochem Pharmacol; 1989 Nov; 38(22):4123-36. PubMed ID: 2480793
[TBL] [Abstract][Full Text] [Related]
4. Cyclic nucleotide phosphodiesterase. Partial purification and characterization of a high affinity enzyme activity from human lung tissue.
Bergstrand H; Lundquist B; Schurmann A
J Biol Chem; 1978 Mar; 253(6):1881-91. PubMed ID: 204635
[TBL] [Abstract][Full Text] [Related]
5. Evidence for convertible forms of soluble uterine cyclic nucleotide phosphodiesterase.
Strada SJ; Epstein PM; Gardner EA; Thompson WJ; Stancel GM
Biochim Biophys Acta; 1981 Sep; 661(1):12-20. PubMed ID: 6271215
[TBL] [Abstract][Full Text] [Related]
6. The catalytic subunit of protein kinase A triggers activation of the type V cyclic GMP-specific phosphodiesterase from guinea-pig lung.
Burns F; Rodger IW; Pyne NJ
Biochem J; 1992 Apr; 283 ( Pt 2)(Pt 2):487-91. PubMed ID: 1315515
[TBL] [Abstract][Full Text] [Related]
7. Purification and kinetic properties of two soluble forms of calmodulin-dependent cyclic nucleotide phosphodiesterase from rat pancreas.
Vandermeers A; Vandermeers-Piret MC; Rathe J; Christophe J
Biochem J; 1983 May; 211(2):341-7. PubMed ID: 6307278
[TBL] [Abstract][Full Text] [Related]
8. Ca2+-independent cyclic GMP phosphodiesterases from rat liver and HTC hepatoma cells.
Strewler GJ; Danello MA; Manganiello VC; Vaughan M
Biochem J; 1983 Aug; 213(2):379-86. PubMed ID: 6311163
[TBL] [Abstract][Full Text] [Related]
9. Characterization of a calmodulin-dependent high-affinity cyclic AMP and cyclic GMP phosphodiesterase from male mouse germ cells.
Geremia R; Rossi P; Mocini D; Pezzotti R; Conti M
Biochem J; 1984 Feb; 217(3):693-700. PubMed ID: 6324744
[TBL] [Abstract][Full Text] [Related]
10. Characterization of a Ca2+-calmodulin-stimulated cyclic GMP phosphodiesterase from bovine brain.
Shenolikar S; Thompson WJ; Strada SJ
Biochemistry; 1985 Jan; 24(3):672-8. PubMed ID: 2986683
[TBL] [Abstract][Full Text] [Related]
11. Interaction of the catalytic subunit of protein kinase A with the lung type V cyclic GMP phosphodiesterase: modulation of non-catalytic binding sites.
Burns F; Pyne NJ
Biochem Biophys Res Commun; 1992 Dec; 189(3):1389-96. PubMed ID: 1336365
[TBL] [Abstract][Full Text] [Related]
12. Inhibitory effect of regucalcin on Ca2+/calmodulin-dependent cyclic AMP phosphodiesterase activity in rat kidney cytosol.
Yamaguchi M; Kurota H
Mol Cell Biochem; 1997 Dec; 177(1-2):209-14. PubMed ID: 9450664
[TBL] [Abstract][Full Text] [Related]
13. Effects of pH on allosteric and catalytic properties of the guanosine cyclic 3',5'-phosphate stimulated cyclic nucleotide phosphodiesterase from calf liver.
Wada H; Osborne JC; Manganiello VC
Biochemistry; 1987 Oct; 26(20):6565-70. PubMed ID: 2447936
[TBL] [Abstract][Full Text] [Related]
14. Pig aortic endothelial-cell cyclic nucleotide phosphodiesterases. Use of phosphodiesterase inhibitors to evaluate their roles in regulating cyclic nucleotide levels in intact cells.
Souness JE; Diocee BK; Martin W; Moodie SA
Biochem J; 1990 Feb; 266(1):127-32. PubMed ID: 2155604
[TBL] [Abstract][Full Text] [Related]
15. Role of selective cyclic GMP phosphodiesterase inhibition in the myorelaxant actions of M&B 22,948, MY-5445, vinpocetine and 1-methyl-3-isobutyl-8-(methylamino)xanthine.
Souness JE; Brazdil R; Diocee BK; Jordan R
Br J Pharmacol; 1989 Nov; 98(3):725-34. PubMed ID: 2480168
[TBL] [Abstract][Full Text] [Related]
16. Characterization and selective inhibition of cyclic nucleotide phosphodiesterase isozymes in canine tracheal smooth muscle.
Torphy TJ; Cieslinski LB
Mol Pharmacol; 1990 Feb; 37(2):206-14. PubMed ID: 2154670
[TBL] [Abstract][Full Text] [Related]
17. Effects of divalent metals on the specificity of inhibitors of the cyclic nucleotide phosphodiesterases from bovine heart.
Donnelly TE; Barron B
Biochim Biophys Acta; 1981 Jan; 657(1):168-78. PubMed ID: 6260197
[TBL] [Abstract][Full Text] [Related]
18. Purification and characterization of a cyclic GMP-stimulated cyclic nucleotide phosphodiesterase from the cytosol of human platelets.
Grant PG; Mannarino AF; Colman RW
Thromb Res; 1990 Jul; 59(1):105-19. PubMed ID: 2169075
[TBL] [Abstract][Full Text] [Related]
19. Characterization of a rat liver cyclic GMP-activated phosphodiesterase by chromatography on hexyl-agarose. Inhibition of phosphodiesterase activity by hexyl-agarose.
Couchie D; Erneux C; Dumont JE
Biochem J; 1981 Nov; 199(2):441-6. PubMed ID: 6280669
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological inhibition of calmodulin-sensitive phosphodiesterases.
Ilien B; Ruckstuhl M; Landry Y
J Pharmacol; 1982; 13(2):307-16. PubMed ID: 6285085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]